Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

Published Jun 25, 2020

Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

During a clinical trial, researchers found that CDK4/CDK6 inhibitor Verzenio may have a huge impact on women battling early stage breast cancer by decreasing the likelihood of the cancer returning.

NOW
PLAYING
Hamilton's Mandy Gonzalez Wrapped Breast Cancer Treatment in April, Will Sing in "A Capitol Fourth"Special on PBS
NOW
PLAYING
PARP Inhibitors for Ovarian Cancer
NOW
PLAYING
New Hope For Esophageal Cancer Patients -- Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
NOW
PLAYING
What to Know About Ovarian Cancer Recurrence
NOW
PLAYING
Genetic Testing For Ovarian Cancer: Why Is It Important?
NOW
PLAYING
' I Made as Much Lemonade Out of These Lemons as I Could' - Survivor Rachel Miller Garcia Shares Her Story

Treatment: Lymphedema

SEE MORE   

Treatment: Lymphedema

Lymphedema is a chronic swelling that can occur after breast cancer surgery and radiation.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.